Zhang Lei portfolio, Q1 2025

HHLR Advisors (Hillhouse) · 13F for the quarter ending Mar 31, 2025

For Q1 2025, HHLR Advisors (Hillhouse) reported $3.5B across 49 US-listed positions, led by PDD (21.9%), BABA (14.6%) and FUTU (12.5%). Compared with its filing for Q4 2024, Zhang Lei opened 11 new positions, added to 8, reduced 10 and sold out of 7; 20 positions did not change.

The largest purchase was an addition to PDD ($453.6M); the largest sale, a reduction of ONC ($753.9M).

Reported value
$3.5B
Positions
49
In the top 10
88%
Filed
May 15
2025

Key facts

13F portfolio value
$3.5BQ1 2025
Positions
49
Largest holding
PDD 21.9%
New positions
11
Sold out
7
Filed
May 15, 2025

Holdings as of (Q1 2025), filed with the SEC on . Changes are measured against the filing for Dec 31, 2024. Every tracked investor's Q1 2025 13F.

Bought and sold in Q1 2025

Zhang Lei: buys and sells in Q1 2025
StockMoveSharesSizeOf portfolio
Beone Medicines LtdONC▼ Reduced 73%−2.77M$753.9M21.3%
PDD Holdings IncPDD▲ Added 140%+3.83M$453.6M12.8%
Futu Holdings LtdFUTU▲ Added 285%+3.19M$326.4M9.22%
Alibaba Group Holding LtdBABA▼ Reduced 20%−979.55K$129.5M3.66%
Vipshop Holdings LtdVIPS▼ Reduced 55%−8.2M$128.5M3.63%
JD.com IncJD▲ Added 185%+3.12M$128.4M3.63%
Kiniksa Pharmaceuticals InternationalKNSA▼ Sold out−1.58M$31.3M0.88%
Bridgebio Pharma IncBBIO▼ Sold out−1.02M$28.1M0.79%
Baidu IncBIDU▲ New+170K$15.6M0.44%
LI Auto IncLI▲ New+620K$15.6M0.44%
Yum China Holdings IncYUMC▲ New+292.12K$15.2M0.43%
KE Holdings IncBEKE▲ Added 6.3%+712.13K$14.3M0.40%
Kanzhun LimitedBZ▲ New+576.34K$11M0.31%
H World Group LtdHTHT▲ New+237.33K$8.8M0.25%
NetEase IncNTES▲ Added 3.1%+79.75K$8.2M0.23%
Atour Lifestyle Holdings LtdATAT▲ New+242.34K$6.9M0.19%
Maze Therapeutics IncMAZE▲ New+457.54K$5M0.14%
Zto Express Cayman IncZTO▲ Added 54%+235.46K$4.7M0.13%
Sohu.com LtdSOHU▼ Reduced 61%−309.05K$4.1M0.11%
GE Vernova IncGEV▼ Sold out−7.83K$2.6M0.07%
Taiwan Semiconductor Manufacturing Company LtdTSM▼ Reduced 23%−9.59K$1.6M0.04%
Trip.com Group LtdTCOM▲ Added 2.7%+25K$1.6M0.04%
China Yuchai International LtdCYD▲ New+70K$1.2M0.03%
Danaher CorpDHR▼ Reduced 39%−5.05K$1M0.03%
Weibo CorpWB▲ New+100K$947K0.03%
Trane Technologies PLCTT▼ Sold out−2.34K$863.5K0.02%
MSCI IncMSCI▼ Reduced 42%−1.52K$860.7K0.02%
Moodys CorpMCO▼ Reduced 41%−1.84K$856.9K0.02%
Metagenomi IncMGX▼ Reduced 81%−627.07K$852.8K0.02%
Dada Nexus Ltdno ticker on file
▼ Sold out−700K$847K0.02%
X FinancialXYF▲ New+50K$719.5K0.02%
GE AerospaceGE▼ Reduced 35%−3.57K$714.7K0.02%
Pyxis Oncology IncPYXS▼ Sold out−382.61K$596.9K0.02%
Ecarx Holdings IncECX▲ New+400K$504K0.01%
Hello Group IncMOMO▼ Sold out−53.59K$413.2K0.01%
JOYY IncJOYY▲ Added 13%+4K$167.9K0.00%

Holdings at the quarter's end

Zhang Lei holdings, Q1 2025
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q4 2024
1PDD Holdings IncPDD · SPONSORED ADSConsumer Discretionary21.9%$776.7M6.56M$118.354+ qtrs▲ Added 140%
2Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary14.6%$516.7M3.91M$132.234+ qtrs▼ Reduced 20%
3Futu Holdings LtdFUTU · SPON ADS CL AFinancials12.5%$440.9M4.31M$102.354+ qtrs▲ Added 285%
4Beone Medicines LtdONC · SPONSORED ADSHealth Care7.95%$281.5M1.03M$272.174+ qtrs▼ Reduced 73%
5NetEase IncNTES · SPONSORED ADSTechnology7.76%$274.7M2.67M$102.924+ qtrs▲ Added 3.1%
6KE Holdings IncBEKE · SPONSORED ADSReal Estate6.80%$240.5M11.97M$20.094+ qtrs▲ Added 6.3%
7Legend Biotech CorpLEGN · SPONSORED ADSHealth Care5.74%$203.1M5.98M$33.934+ qtrsNo change
8JD.com IncJD · SPON ADS CL AConsumer Discretionary5.59%$197.9M4.81M$41.124+ qtrs▲ Added 185%
9Vipshop Holdings LtdVIPS · SPONSORED ADS AConsumer Discretionary2.96%$104.8M6.68M$15.684+ qtrs▼ Reduced 55%
10
WNS Holdings Ltdno ticker on file
—2.66%$94.2M1.53M$61.492 qtrsNo change
11Arrivent Biopharma IncAVBP—2.34%$82.9M4.48M$18.494+ qtrsNo change
12Trip.com Group LtdTCOM · ADSConsumer Discretionary1.69%$59.7M938.84K$63.584+ qtrs▲ Added 2.7%
13
Enfusion Incno ticker on file · CL A
—1.57%$55.5M4.98M$11.154+ qtrsNo change
14Yatsen Holding LtdYSG · SPONSORED ADS—0.94%$33.1M6.89M$4.814+ qtrsNo change
15Cytek Biosciences IncCTKB—0.75%$26.7M6.66M$4.014+ qtrsNo change
16Baidu IncBIDU · SPON ADR REP ATechnology0.44%$15.6M170K$92.031 qtrNew
17LI Auto IncLI · SPONSORED ADSConsumer Discretionary0.44%$15.6M620K$25.201 qtrNew
18Yum China Holdings IncYUMCConsumer Discretionary0.43%$15.2M292.12K$52.061 qtrNew
19Zto Express Cayman IncZTO · SPONSORED ADS AIndustrials0.38%$13.3M671.39K$19.844+ qtrs▲ Added 54%
20Kanzhun LimitedBZ · SPONSORED ADSTechnology0.31%$11M576.34K$19.171 qtrNew
21H World Group LtdHTHT · SPONSORED ADSConsumer Discretionary0.25%$8.8M237.33K$37.011 qtrNew
22Agora IncAPI · ADS—0.24%$8.4M2.1M$4.022 qtrsNo change
23Atour Lifestyle Holdings LtdATAT · SPONSORED ADSConsumer Discretionary0.19%$6.9M242.34K$28.351 qtrNew
24Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADSTechnology0.16%$5.5M33K$166.004+ qtrs▼ Reduced 23%
25Gossamer Bio IncGOSS—0.16%$5.5M4.97M$1.104+ qtrsNo change
26Maze Therapeutics IncMAZE—0.14%$5M457.54K$11.011 qtrNew
27Novabridge BiosciencesNBP · SPONSORED ADS—0.14%$4.9M5.98M$0.82394+ qtrsNo change
28Tuya IncTUYA · SPONSERED ADS—0.13%$4.7M1.56M$3.034+ qtrsNo change
29Contineum Therapeutics IncCTNM · CL A—0.13%$4.7M669.34K$6.984+ qtrsNo change
30
Smart SH Global Ltdno ticker on file · ADS
—0.13%$4.4M3.95M$1.124+ qtrsNo change
31Sohu.com LtdSOHU · SPONSORED ADS—0.08%$2.7M201.43K$13.174+ qtrs▼ Reduced 61%
32Sagimet Biosciences IncSGMT—0.07%$2.4M724.8K$3.264+ qtrsNo change
33Mogu IncMOGU · SPON ADS—0.05%$1.9M847.51K$2.214+ qtrsNo change
34
Bright Scholar ED Holdings Ltdno ticker on file · SPON ADS NEW
—0.05%$1.7M988.14K$1.674+ qtrsNo change
35Danaher CorpDHRHealth Care0.05%$1.6M8.03K$205.004+ qtrs▼ Reduced 39%
36JOYY IncJOYY · ADS REPSTG COM A—0.04%$1.4M34K$41.983 qtrs▲ Added 13%
37GE AerospaceGEIndustrials0.04%$1.4M6.76K$200.154+ qtrs▼ Reduced 35%
38Moodys CorpMCOFinancials0.04%$1.2M2.64K$465.694+ qtrs▼ Reduced 41%
39MSCI IncMSCIFinancials0.03%$1.2M2.13K$565.502 qtrs▼ Reduced 42%
40China Yuchai International LtdCYD—0.03%$1.2M70K$16.991 qtrNew
41Pacific Biosciences of California IncPACB—0.03%$1.1M918.89K$1.184+ qtrsNo change
42Weibo CorpWB · SPONSORED ADR—0.03%$947K100K$9.471 qtrNew
43X FinancialXYF · SPONSORED ADS—0.02%$719.5K50K$14.391 qtrNew
44Aligos Therapeutics IncALGS—0.02%$629K76.25K$8.254+ qtrsNo change
45Ecarx Holdings IncECX · CLASS A ORD—0.01%$504K400K$1.261 qtrNew
46Metagenomi IncMGX—0.01%$205K150.7K$1.364+ qtrs▼ Reduced 81%
47
Lakeshore Biopharma Co Ltdno ticker on file · ORD SHS NEW
—0.01%$181.9K75.18K$2.422 qtrsNo change
48Uxin LtdUXIN · SPONSORED ADS—0.00%$76.4K19.16K$3.994+ qtrsNo change
49Ridgetech IncRDGT · SHS NEW—0.00%$21.2K20.17K$1.054+ qtrsNo change

By sector

Zhang Lei portfolio by sector, Q1 2025
SectorShare of portfolioValuePositions
Consumer Discretionary48.1%$1.7B9
Health Care13.7%$486.2M3
Financials12.5%$443.3M3
Technology8.67%$306.8M4
Real Estate6.80%$240.5M1
Industrials0.41%$14.7M2
No sector on file9.76%$345.6M27

Questions and answers

What did Zhang Lei own in Q1 2025?

HHLR Advisors (Hillhouse)'s 13F for Q1 2025 lists 49 positions worth $3.5B. The largest: PDD (21.9%), BABA (14.6%), FUTU (12.5%), ONC (8.0%), NTES (7.8%).

What did Zhang Lei buy in Q1 2025?

The largest purchases, by the shares bought at the quarter-end price the filing implies: PDD (added, $453.6M), FUTU (added, $326.4M), JD (added, $128.4M), BIDU (new, $15.6M), LI (new, $15.6M), YUMC (new, $15.2M).

What did Zhang Lei sell in Q1 2025?

The largest sales: ONC (reduced, $753.9M), BABA (reduced, $129.5M), VIPS (reduced, $128.5M), KNSA (sold out, $31.3M), BBIO (sold out, $28.1M), SOHU (reduced, $4.1M).

When was this filing made?

HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Mar 31, 2025 on May 15, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Zhang Lei portfolio, Q1 2025: HHLR Advisors (Hillhouse) 13F holdings”, data as of 15 May 2025. https://funkfolio.com/gurus/hillhouse/2025-q1

Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Mar 31, 2025.

Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Mar 31, 2025, filed May 15, 2025. Changes compare share counts with the filing for Dec 31, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $3.5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 4 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.